Publication

Moore IMK, Lupo PJ, Insel K, Harris LL, Pasvogel A, Koerner KM, Adkins KB, Taylor OA, Hockenberry MJ. 2016. Neurocognitive Predictors of Academic Outcomes Among Childhood Leukemia Survivors. Cancer Nurs. 39:255–62. doi:10.1097/NCC.0000000000000293.

Bauman JE, Zang Y, Sen M, Li C, Wang L, Egner PA, Fahey JW, Normolle DP, Grandis JR, Kensler TW, et al. 2016. Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane. Cancer Prev Res (Phila). 9:547–57. doi:10.1158/1940-6207.CAPR-15-0290.

Tillotson J, Bashyal BP, Kang M, Shi T, De La Cruz F, Gunatilaka AAL, Chapman E. 2016. Selective inhibition of p97 by chlorinated analogues of dehydrocurvularin. Org Biomol Chem. 14:5918–21. doi:10.1039/c6ob00560h.

Brand JF, Furenlid LR, Altbach MI, Galons J-P, Bhattacharyya A, Sharma P, Bhattacharyya T, Bilgin A, Martin DR. 2016. Task-based optimization of flip angle for fibrosis detection in T1-weighted MRI of liver. J Med Imaging (Bellingham). 3:035502. doi:10.1117/1.JMI.3.3.035502.

Guedon J-MG, Longo G, Majuta LA, Thomspon ML, Fealk MN, Mantyh PW. 2016. Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain. Pain. 157:1239–47. doi:10.1097/j.pain.0000000000000514.

Stratton D, Loescher LJ. 2016. The acceptance of mobile teledermoscopy by primary care nurse practitioners in the state of Arizona. J Am Assoc Nurse Pract. 28:287–93. doi:10.1002/2327-6924.12313.

Stern JH, Rutkowski JM, Scherer PE. 2016. Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. Cell Metab. 23:770–84. doi:10.1016/j.cmet.2016.04.011.

Miles B, Connick E. 2016. TFH in HIV Latency and as Sources of Replication-Competent Virus. Trends Microbiol. 24:338–344. doi:10.1016/j.tim.2016.02.006.

Thapa HR, Naik MT, Okada S, Takada K, Molnár I, Xu Y, Devarenne TP. 2016. A squalene synthase-like enzyme initiates production of tetraterpenoid hydrocarbons in Botryococcus braunii Race L. Nat Commun. 7:11198. doi:10.1038/ncomms11198.

Paek AL, Liu JC, Loewer A, Forrester WC, Lahav G. 2016. Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing. Cell. 165:631–42. doi:10.1016/j.cell.2016.03.025.

Meenach SA, Tsoras AN, McGarry RC, Mansour HM, Hilt JZ, Anderson KW. 2016. Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics. Int J Oncol. 48:1701–9. doi:10.3892/ijo.2016.3376.

Nguyen J, Bernert R, In K, Kang P, Sebastiao N, Hu C, Hastings KT. 2016. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma. Melanoma Res. 26:125–37. doi:10.1097/CMR.0000000000000230.

Loh MM, Sugeng A, Lothrop N, Klimecki W, Cox M, Wilkinson ST, Lu Z, Beamer PI. 2016. Multimedia exposures to arsenic and lead for children near an inactive mine tailings and smelter site. Environ Res. 146:331–9. doi:10.1016/j.envres.2015.12.011.

Munger SJ, Geng X, Srinivasan RS, Witte MH, Paul DL, Simon AM. 2016. Segregated Foxc2, NFATc1 and Connexin expression at normal developing venous valves, and Connexin-specific differences in the valve phenotypes of Cx37, Cx43, and Cx47 knockout mice. Dev Biol. 412:173–90. doi:10.1016/j.ydbio.2016.02.033.

Peela N, Sam FS, Christenson W, Truong D, Watson AW, Mouneimne G, Ros R, Nikkhah M. 2016. A three dimensional micropatterned tumor model for breast cancer cell migration studies. Biomaterials. 81:72–83. doi:10.1016/j.biomaterials.2015.11.039.

Caviness K, Bughio F, Crawford LB, Streblow DN, Nelson JA, Caposio P, Goodrum F. 2016. Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency. MBio. 7:e01986. doi:10.1128/mBio.01986-15.

Bai J, Lu Y, Xu Y-M, Zhang W, Chen M, Lin M, Gunatilaka AAL, Xu Y, Molnár I. 2016. Diversity-Oriented Combinatorial Biosynthesis of Hybrid Polyketide Scaffolds from Azaphilone and Benzenediol Lactone Biosynthons. Org Lett. 18:1262–5. doi:10.1021/acs.orglett.6b00110.

Kohler SL, Pham MN, Folkvord JM, Arends T, Miller SM, Miles B, Meditz AL, McCarter M, Levy DN, Connick E. 2016. Germinal Center T Follicular Helper Cells Are Highly Permissive to HIV-1 and Alter Their Phenotype during Virus Replication. J Immunol. 196:2711–22. doi:10.4049/jimmunol.1502174.

Dickinson SE, Janda J, Criswell J, Blohm-Mangone K, Olson ER, Liu Z, Barber C, Petricoin EF, Calvert VS, Einspahr J, et al. 2016. Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin. Cancer Prev Res (Phila). 9:215–24. doi:10.1158/1940-6207.CAPR-15-0419.

Zhang L, Zhou Z, Guo Q, Fokkens L, Miskei M, Pócsi I, Zhang W, Chen M, Wang L, Sun Y, et al. 2016. Insights into Adaptations to a Near-Obligate Nematode Endoparasitic Lifestyle from the Finished Genome of Drechmeria coniospora. Sci Rep. 6:23122. doi:10.1038/srep23122.

Koblansky AA, Truax AD, Liu R, Montgomery SA, Ding S, Wilson JE, Brickey WJ, Mühlbauer M, McFadden R-MT, Hu P, et al. 2016. The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals. Cell Rep. 14:2562–75. doi:10.1016/j.celrep.2016.02.064.

López AM, Pruthi S, Boughey JC, Perloff M, Hsu C-H, Lang JE, Ley M, Frank D, Taverna JA, Chow H-HS. 2016. Double-Blind, Randomized Trial of Alternative Letrozole Dosing Regimens in Postmenopausal Women with Increased Breast Cancer Risk. Cancer Prev Res (Phila). 9:142–8. doi:10.1158/1940-6207.CAPR-15-0322.

Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo M, Weber RS, Kies M, Lozano G, Futreal PA, Caulin C, et al. 2016. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clin Cancer Res. 22:725–33. doi:10.1158/1078-0432.CCR-15-2867-T.

Weterings E, Gallegos AC, Dominick LN, Cooke LS, Bartels TN, Vagner J, Matsunaga TO, Mahadevan D. 2016. A novel small molecule inhibitor of the DNA repair protein Ku70/80. DNA Repair (Amst). 43:98–106. doi:10.1016/j.dnarep.2016.03.014.

Puvvada SD, Li H, Rimsza LM, Bernstein SH, Fisher RI, LeBlanc M, Schmelz M, Glinsmann-Gibson B, Miller TP, Maddox A-M, et al. 2016. A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520. Leuk Lymphoma. 57:2359–69. doi:10.3109/10428194.2015.1135431.